is a recombinant factor replacement that helps treat hemophilia A, which is a deficiency of Factor VIII in the blood. A lack of Factor VIII prevents blood from clotting. hemophilia treatment is then used to help control and prevent episodes of excessive bleeding in adults and children.
A trained healthcare professional is necessary to administer this treatment. This is due to the fact that hemophilia treatment requires intravenous administration. You should choose to have a doctor who has hemophilia A experience administer your first dose.
The dosage amount depends on the severity of a patient’s case of hemophilia. This decision is usually made by a doctor or healthcare professional before the initial dosage.
The time between doses will also depend on the severity of a patient’s condition of hemophilia. The severity comes in three different categories of bleeding, including Minor Bleeding, Moderate Bleeding, and Major Bleeding.
Minor Bleeding consists of minor muscle bleeding, bleeding from the mouth, or early hemarthrosis. Moderate Bleeding can include mild head trauma, bleeding into the muscles, and bleeding into the mouth. Major Bleeding can include gastrointestinal bleeding, abdominal bleeding, head injuries, and fractures.
doses for Minor Bleeding usually lasts within a day, or until the bleeding stops or is contained. Moderate Bleeding duration can be between three to four days. Whereas, Major Bleeding should last until the bleeding is resolved or controlled.
It is important to talk with your doctor before you consider hemophilia treatment as your main treatment option. After discussion with a professional, you should be able to determine if hemophilia will provide the best results. Furthermore, your doctor can offer you other options if is not appropriate.
Please note that this treatment is not meant for patients with von Willebrand’s disease because it does not have the von Willebrand factor.
Featured Image: DepositPhotos/vitanovski